stoxline Quote Chart Rank Option Currency Glossary
  
Isoray, Inc. (ISR)
0.384  0 (0%)    02-17 16:00
Open: 0.3724
High: 0.39
Volume: 145,041
  
Pre. Close: 0.3839
Low: 0.3613
Market Cap: 0(M)
Technical analysis
2023-05-05 4:21:12 PM
Short term     
Mid term     
Targets 6-month :  0.81 1-year :  0.95
Resists First :  0.69 Second :  0.81
Pivot price 0.66
Supports First :  0.57 Second :  0.5
MAs MA(5) :  0.66 MA(20) :  0.64
MA(100) :  0.42 MA(250) :  0.36
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  88.3 D(3) :  82.2
RSI RSI(14): 61.8
52-week High :  0.69 Low :  0.19
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ ISR ] has closed below upper band by 25.7%. Bollinger Bands are 32.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.69 - 0.7 0.7 - 0.7
Low: 0.64 - 0.64 0.64 - 0.64
Close: 0.68 - 0.69 0.69 - 0.7
Company Description

Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. Isoray, Inc. was founded in 1998 and is based in Richland, Washington.

Headline News

Thu, 14 Mar 2024
IsoRay: Fiscal 2Q Earnings Snapshot - Yahoo Movies Canada

Wed, 08 Feb 2023
Medtech companies merge to form Perspective Therapeutics - Corridor Business

Tue, 07 Feb 2023
Isoray Completes Merger with Viewpoint Molecular - FinSMEs

Mon, 06 Feb 2023
Isoray Completes Merger with Viewpoint Molecular Targeting to Advance New Treatment Paradigm in Targeted ... - Business Wire

Thu, 20 Oct 2022
Isoray Stock: Not Going Anywhere Anytime Soon (NYSE:ISR) - Seeking Alpha

Tue, 18 Oct 2022
Isoray Medical, Inc. and Viewpoint Molecular Targeting, Inc. Announce Investor Webcast on October 19, 2022 at 4:15 ... - Business Wire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
AMEX
Sector:
Healthcare
Industry:
Medical Devices
Shares Out 142 (M)
Shares Float 140 (M)
Held by Insiders 0.8 (%)
Held by Institutions 11.2 (%)
Shares Short 1,150 (K)
Shares Short P.Month 1,580 (K)
Stock Financials
EPS -0.04
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0.05
Book Value (p.s.) 0.46
Profit Margin -48.1 %
Operating Margin -48.9 %
Return on Assets (ttm) -8.2 %
Return on Equity (ttm) -13.9 %
Qtrly Rev. Growth 7.5 %
Gross Profit (p.s.) 0.03
Sales Per Share 0.07
EBITDA (p.s.) -0.04
Qtrly Earnings Growth 0 %
Operating Cash Flow -5 (M)
Levered Free Cash Flow -3 (M)
Stock Valuations
PE Ratio -17.25
PEG Ratio 0
Price to Book value 1.49
Price to Sales 9.56
Price to Cash Flow -21.38
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android